Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma.

Molecular oncology - 1 Nov 2024

Bos Manouk K, Kraan Jaco, Starmans Martijn P A, Helmijr Jean C A, Verschoor Noortje, De Jonge Maja J A, Joosse Arjen, van der Veldt Astrid A M, Te Boekhorst Peter A W, Martens John W M, Sleijfer Stefan, Wilting Saskia M

Abstract excerpt

Advances in therapeutic approaches for melanoma urge the need for biomarkers that can identify patients at risk for recurrence and to guide treatment. The potential use of liquid biopsies in identifying biomarkers is increasingly being recognized. Here, we present a head-to-head comparison of several techniques to analyze circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in 20 patients with metastatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aneuploidy
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to DNA Methylation

Share to Liquid Biopsy

Share to Melanoma

Share to Neoplasm Metastasis

Share to Neoplastic Cells, Circulating

Source

Open in PubMed Open full text

Identifiers

PMID: 38790134
DOI: 10.1002/1878-0261.13650
PMCID: PMC11547238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma.PMID 38790134Read ↗

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cellsSemantic proximity Read ↗

Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.Semantic proximity Read ↗

Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.Semantic proximity Read ↗

Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.Semantic proximity Read ↗

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma PatientsSemantic proximity Read ↗

In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibitionSemantic proximity Read ↗

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNASemantic proximity Read ↗

Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.Semantic proximity Read ↗

Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid BiopsySemantic proximity Read ↗

Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.Semantic proximity Read ↗

Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.Semantic proximity Read ↗

Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.